Skip to content

49% of clinical trial disruption due to slow enrollment

The Covid-19 pandemic had a strong impact on clinical trials at a global scale, disrupting clinical trials from April 2020.

According to a recent report from Global Data, slow enrollment is the main cause accounting for 49% of disrupted clinical trials.
The second is enrollment suspension (35%) and the third is delayed initiation (16%).

Full article here: https://www.globaldata.com/49-clinical-trial-disruption-due-slow-enrollment/#:~:text=As%20of%20November%2030%2C%202020,leading%20data%20and%20analytics%20company

Our web application CT-SCOUT™ aims to accelerate the detection of potentially eligible patients for clinical trials at site in order to increase recruitment and indeed to reduce delays in clinical trials.

Click here to request a demo: https://www.ctma.fr/contact-us/

La version de votre navigateur est obsolète et votre appareil est exposé à des risques de sécurité.

Pour profiter d'une expérience optimale sur ce site il est fortement recommandé de mettre à jour votre navigateur ou d'en installer un autre :